• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Preoperative taxol induces objective responses in primary breast cancer not responding to FEC treatment.

作者信息

Steger G G, Djavanmard M P, Gnant M F, Jakesz R

出版信息

Ann Oncol. 1994 Nov;5(9):863-4. doi: 10.1093/oxfordjournals.annonc.a059024.

DOI:10.1093/oxfordjournals.annonc.a059024
PMID:7848893
Abstract
摘要

相似文献

1
Preoperative taxol induces objective responses in primary breast cancer not responding to FEC treatment.术前使用紫杉醇可使对FEC治疗无反应的原发性乳腺癌产生客观反应。
Ann Oncol. 1994 Nov;5(9):863-4. doi: 10.1093/oxfordjournals.annonc.a059024.
2
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.氟尿嘧啶、表柔比星和环磷酰胺单药或序贯紫杉醇用于早期乳腺癌的随机3期试验。
J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27.
3
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.一项针对原发性乳腺癌女性患者的II期研究，采用氟尿嘧啶、表柔比星和环磷酰胺每14天第1天和第4天的剂量密集方案，并给予非格司亭支持，随后每周使用紫杉醇。
Oncologist. 2015 Mar;20(3):239-40. doi: 10.1634/theoncologist.2014-0326. Epub 2015 Jan 30.
4
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.氟尿嘧啶、表柔比星和环磷酰胺个体化治疗与骨髓支持的大剂量化疗作为高危乳腺癌辅助治疗的比较：一项随机试验。斯堪的纳维亚乳腺癌研究组9401研究。
Lancet. 2000 Oct 21;356(9239):1384-91. doi: 10.1016/s0140-6736(00)02841-5.
5
Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers.使用 70 基因分类器预测乳腺癌序贯紫杉醇和 5-氟尿嘧啶/表柔比星/环磷酰胺治疗的病理完全缓解。
Cancer. 2011 Aug 15;117(16):3682-90. doi: 10.1002/cncr.25953. Epub 2011 Feb 8.
6
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer.一项关于节拍式紫杉醇/环磷酰胺/卡培他滨序贯氟尿嘧啶/表柔比星/环磷酰胺作为三阴性或低激素受体表达/HER2 阴性原发性乳腺癌术前化疗的 II 期研究。
Cancer Chemother Pharmacol. 2014 Aug;74(2):229-38. doi: 10.1007/s00280-014-2492-y. Epub 2014 May 29.
7
The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial.每三周一次白蛋白结合型紫杉醇与环磷酰胺术前化疗，随后进行氟尿嘧啶、表柔比星和环磷酰胺治疗对可切除乳腺癌的疗效和安全性：一项多中心临床试验
Clin Breast Cancer. 2015 Apr;15(2):110-6. doi: 10.1016/j.clbc.2014.09.010. Epub 2014 Oct 2.
8
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01).一项关于晚期乳腺癌序贯使用5-氟尿嘧啶、表柔比星和环磷酰胺（FEC）及紫杉醇的II期研究（方案PV BC 97/01）。
Br J Cancer. 2001 Jul 20;85(2):141-6. doi: 10.1054/bjoc.2001.1897.
9
[A case of left breast cancer resulting in complete response by primary systemic therapy].
Gan To Kagaku Ryoho. 2007 Sep;34(9):1497-500.
10
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.5-氟尿嘧啶、表柔比星和环磷酰胺与表柔比星和紫杉醇治疗淋巴结阳性早期乳腺癌的疗效比较：一项GONO-MIG5 III期随机试验
Breast Cancer Res Treat. 2016 Jan;155(1):117-26. doi: 10.1007/s10549-015-3655-1. Epub 2015 Dec 10.

引用本文的文献

1
Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27.紫杉醇和表柔比星对人乳腺癌R-27的抗肿瘤活性
Folia Microbiol (Praha). 1998;43(5):473-4. doi: 10.1007/BF02820793.